Literature DB >> 27735233

The analysis of serum lipid levels in patients with spinal cord injury.

Engin Koyuncu1, Güldal Funda Nakipoğlu Yüzer1, Didem Yenigün1, Neşe Özgirgin1.   

Abstract

STUDY
DESIGN: Retrospective study.
OBJECTIVES: The purposes of this investigation were to evaluate the serum lipid profile among a broad sample of patients with spinal cord injury (SCI), examining the impact of disease duration, lesion level, lesion grade and functional activity level on serum lipid levels of patients with SCI.
SETTING: Ankara Physical Medicine and Rehabilitation Training and Research Hospital, Turkey.
METHODS: Serum lipid profiles of 269 participants with SCI were analyzed and correlated to disease duration, lesion level, lesion grade and ambulation status.
RESULTS: Total cholesterol (TC) was higher than normal in 21.2%, low density lipoprotein cholesterol in 24.4%, and triglycerides levels in 31% of the patients. The high density lipoprotein cholesterol (HDL-c) level was found to be lower than 40 mg/dl in 79.5% of the patients, TC/HDL-c ratio was 4.5 and above in 65.7% of the patients in our study. TC/HDL-c ratio was significantly higher in patients with SCI with a disease duration of 0-12 months than the group with a longer disease duration (P = 0.009). TC/HDL-c ratio was significantly higher in patients who could not be community ambulated than the patients who were community ambulated (P = 0.005). HDL-c levels in patients with motor complete SCI were significantly lower than patients with motor incomplete SCI (P = 0.028).
CONCLUSION: Dyslipidemia is observed in a large number of patients with SCI. The risk of dyslipidemia was seen to have increased in motor complete SCI patients, in patients who can not be community ambulated and whose disease duration is between 0 to 12 months.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27735233      PMCID: PMC5815153          DOI: 10.1080/10790268.2016.1228286

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  27 in total

1.  Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort.

Authors:  W A Bauman; R H Adkins; A M Spungen; R Herbert; C Schechter; D Smith; B J Kemp; R Gambino; P Maloney; R L Waters
Journal:  Spinal Cord       Date:  1999-07       Impact factor: 2.772

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Causes of death following spinal cord injury during inpatient rehabilitation and the first five years after discharge. A Dutch cohort study.

Authors:  R Osterthun; M W M Post; F W A van Asbeck; C M C van Leeuwen; C F van Koppenhagen
Journal:  Spinal Cord       Date:  2014-04-01       Impact factor: 2.772

Review 4.  Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management.

Authors:  Jonathan Myers; Matthew Lee; Jenny Kiratli
Journal:  Am J Phys Med Rehabil       Date:  2007-02       Impact factor: 2.159

5.  Mortality after spinal cord injury in Norway.

Authors:  Ingeborg Beate Lidal; Hildegun Snekkevik; Geir Aamodt; Nils Hjeltnes; Fin Biering-Sørensen; Johan Kvalvik Stanghelle
Journal:  J Rehabil Med       Date:  2007-03       Impact factor: 2.912

6.  Lipid profile in spinal cord-injured women with different injury levels.

Authors:  Max-Jürgen Storch; Daniel König; Dirk Bültermann; Andreas Blum; Stefan Vogt; Manfred Baumstark; Aloys Berg; Andreas Schmid
Journal:  Prev Med       Date:  2005-03       Impact factor: 4.018

Review 7.  Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury.

Authors:  Timothy J Wilt; Kathleen F Carlson; Gary D Goldish; Roderick MacDonald; Catherine Niewoehner; Indulis Rutks; Tatyana Shamliyan; James Tacklind; Brent C Taylor; Robert L Kane
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2008-01

Review 8.  Serum lipid concentrations among persons with spinal cord injury - a systematic review and meta-analysis of the literature.

Authors:  Olivia Gilbert; James R Croffoot; Allen J Taylor; Mark Nash; Katherine Schomer; Suzanne Groah
Journal:  Atherosclerosis       Date:  2013-11-18       Impact factor: 5.162

9.  The relationships among serum uric acid, plasma insulin, and serum lipoprotein levels in subjects with spinal cord injury.

Authors:  Y G Zhong; E Levy; W A Bauman
Journal:  Horm Metab Res       Date:  1995-06       Impact factor: 2.936

10.  Mortality after traumatic spinal cord injury: 50 years of follow-up.

Authors:  Ellen Merete Hagen; Stein Atle Lie; Tiina Rekand; Nils Erik Gilhus; Marit Gronning
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-02       Impact factor: 10.154

View more
  7 in total

1.  Assessment of quality of life in relation to spasticity severity and socio-demographic and clinical factors among patients with spinal cord injury.

Authors:  Meltem Vural; Ebru Yilmaz Yalcinkaya; Evrim Coskun Celik; Berrin Gunduz; Ahmet Bozan; Belgin Erhan
Journal:  J Spinal Cord Med       Date:  2018-12-03       Impact factor: 1.985

2.  Effects of walking training on risk markers of cardiovascular disease in individuals with chronic spinal cord injury.

Authors:  Ramzi A Alajam; Abdulfattah S Alqahtani; Sanghee Moon; Caio V M Sarmento; Jason Frederick; Irina V Smirnova; Wen Liu
Journal:  J Spinal Cord Med       Date:  2021-01-14       Impact factor: 2.040

3.  Development of Cardiometabolic Health indicators to advance the quality of spinal cord injury rehabilitation: SCI-High Project.

Authors:  Matheus J Wiest; Christopher West; David Ditor; Julio C Furlan; Masae Miyatani; Farnoosh Farahani; S Mohammad Alavinia; Paul I Oh; Mark T Bayley; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

4.  Abnormal fatty acid metabolism is a core component of spinal muscular atrophy.

Authors:  Marc-Olivier Deguise; Giovanni Baranello; Chiara Mastella; Ariane Beauvais; Jean Michaud; Alessandro Leone; Ramona De Amicis; Alberto Battezzati; Christopher Dunham; Kathryn Selby; Jodi Warman Chardon; Hugh J McMillan; Yu-Ting Huang; Natalie L Courtney; Alannah J Mole; Sabrina Kubinski; Peter Claus; Lyndsay M Murray; Melissa Bowerman; Thomas H Gillingwater; Simona Bertoli; Simon H Parson; Rashmi Kothary
Journal:  Ann Clin Transl Neurol       Date:  2019-07-26       Impact factor: 4.511

5.  Regulation of Inflammasomes by Application of Omega-3 Polyunsaturated Fatty Acids in a Spinal Cord Injury Model.

Authors:  Maryam Baazm; Victoria Behrens; Cordian Beyer; Omid Nikoubashman; Adib Zendedel
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

Review 6.  The Diagnosis and Management of Cardiometabolic Risk and Cardiometabolic Syndrome after Spinal Cord Injury.

Authors:  Gary J Farkas; Adam M Burton; David W McMillan; Alicia Sneij; David R Gater
Journal:  J Pers Med       Date:  2022-06-30

7.  Bioinformatic Analysis of the Proteome in Exosomes Derived From Plasma: Exosomes Involved in Cholesterol Metabolism Process of Patients With Spinal Cord Injury in the Acute Phase.

Authors:  Chunshuai Wu; Jinjuan Yu; Guanhua Xu; Hong Gao; Yue Sun; Jiayi Huang; Li Sun; Xu Zhang; Zhiming Cui
Journal:  Front Neuroinform       Date:  2021-07-09       Impact factor: 4.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.